Works matching IS 00302414 AND DT 2023 AND VI 101

Results: 108

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 12, p. 764, doi. 10.1159/000535850
Publication type:: Article

Contents Vol. 101, 2023.

Published in:: Oncology, 2023, v. 101, n. 12, p. I, doi. 10.1159/000535209
Publication type:: Article

Erratum.

Published in:: 2023
Publication type:: Correction Notice

High-Mobility Group Box 1 Overexpression Predicts a Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Activating TLR4/NF-κB Signaling.

Published in:

Oncology, 2023, v. 101, n. 12, p. 786, doi. 10.1159/000533927

By:

Ma, Jichun;
Da, Mingxu

Publication type:

Article

The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic Drug.

Published in:

Oncology, 2023, v. 101, n. 12, p. 836, doi. 10.1159/000533866

By:

Jørgensen, Jan Trøst

Publication type:

Article

Retrospective Study of Treatment Patterns and Natural History of Patients with T1a/b N0 Triple-Negative Breast Cancers: A Single-Institution Experience.

Published in:

Oncology, 2023, v. 101, n. 12, p. 765, doi. 10.1159/000533149

By:

Liu, Langfeier;
Lewis, Nicholas;
Sun, Weihong;
Whiting, Junmin;
Hoover, Susan;
Costa, Ricardo L.B.

Publication type:

Article

Significance of Ultra-Radical Surgery in Extensive Metastatic Ovarian Growing Teratoma Syndrome.

Published in:

Oncology, 2023, v. 101, n. 12, p. 773, doi. 10.1159/000533411

By:

Li, Sijian;
Wang, Tao;
Du, Huayang;
Tang, Hui;
Zhang, Tianyu;
Zhang, Rundong;
Zhang, Xinyue;
Yang, Jiaxin

Publication type:

Article

Comparing COVID-19 Response Behaviors between a Cancer Patient Sample and a Population-Based Cancer-Free Sample in a Rural Midwestern State.

Published in:

Oncology, 2023, v. 101, n. 12, p. 808, doi. 10.1159/000533408

By:

Greteman, Breanna B.;
Garcia-Auguste, Crystal J.;
Kahl, Amanda R.;
Gryzlak, Brian M.;
Chrischilles, Elizabeth A.;
Charlton, Mary E.;
Nash, Sarah H.

Publication type:

Article

Evaluation of Time to Onset and Outcome of Cardiac Adverse Events Associated with Nilotinib using Post-Marketing Surveillance.

Published in:

Oncology, 2023, v. 101, n. 12, p. 799, doi. 10.1159/000533325

By:

Kanbayashi, Yuko;
Kojima, Asuka;
Wakabayashi, Haruka;
Shimizu, Tadashi;
Uchida, Mayako

Publication type:

Article

Efficacy of Autologous Hematopoietic Stem Cell Transplantation versus Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation for Follicular Lymphoma: Systematic Review and Meta-Analysis.

Published in:

Oncology, 2023, v. 101, n. 12, p. 822, doi. 10.1159/000532090

By:

Liu, Xinsheng;
Zheng, Yaxin;
Li, Hongtao;
Wang, Meiyi;
You, M. James;
Tian, Chen

Publication type:

Article

Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database.

Published in:

Oncology, 2023, v. 101, n. 12, p. 782, doi. 10.1159/000533539

By:

Ohta, Hiroaki;
Horii, Takeshi;
Yasu, Takeo

Publication type:

Article

Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing Surveillance.

Published in:

Oncology, 2023, v. 101, n. 12, p. 817, doi. 10.1159/000533302

By:

Kanbayashi, Yuko;
Kobayashi, Momoko;
Anzai, Miku;
Shimizu, Tadashi;
Uchida, Mayako

Publication type:

Article

Circulating Cell-Free DNA as a Biomarker for Prognosis and Response to Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 11, p. 714, doi. 10.1159/000531671

By:

Watanabe, Takuya;
Suzuki, Yuji;
Kuroda, Hidekatsu;
Hiraki, Hayato;
Suzuki, Akiko;
Tamura, Akio;
Ieko, Yoshiro;
Nishizuka, Satoshi S.;
Matsumoto, Takayuki

Publication type:

Article

Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver Cancer.

Published in:

Oncology, 2023, v. 101, n. 11, p. 738, doi. 10.1159/000533303

By:

Akuta, Norio;
Kawamura, Yusuke;
Fujiyama, Shunichiro;
Sezaki, Hitomi;
Hosaka, Tetsuya;
Saitoh, Satoshi;
Kobayashi, Mariko;
Arase, Yasuji;
Ikeda, Kenji;
Suzuki, Yoshiyuki;
Kumada, Hiromitsu;
Suzuki, Fumitaka

Publication type:

Article

Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Published in:

Oncology, 2023, v. 101, n. 11, p. 753, doi. 10.1159/000531576

By:

Yucel, Orhan Kemal;
Vural, Ece;
Alhan, Nurcan;
Vurgun, Sertac;
Atas, Unal;
Yapar, Dilek;
Alemdar, Mustafa Serkan;
Karaca, Mustafa;
Iltar, Utku;
Salim, Ozan;
Undar, Levent

Publication type:

Article

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 11, p. 1, doi. 10.1159/000534780
Publication type:: Article

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 10, p. 1, doi. 10.1159/000534426
Publication type:: Article

Overexpression of SOX2 Gene by Histone Modifications: SOX2 Enhances Human Prostate and Breast Cancer Progression by Prevention of Apoptosis and Enhancing Cell Proliferation.

Published in:

Oncology, 2023, v. 101, n. 9, p. 591, doi. 10.1159/000531195

By:

Kar, Swayamsiddha;
Niharika;
Roy, Ankan;
Patra, Samir Kumar

Publication type:

Article

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Published in:

Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Postoperative Early Body Weight Loss Is a Risk Factor for Recurrence in Patients with pStage III Gastric Cancer.

Published in:

Oncology, 2023, v. 101, n. 11, p. 705, doi. 10.1159/000532089

By:

Fujimoto, Daisuke;
Taniguchi, Keizo;
Takashima, Junpei;
Kobayashi, Hirotoshi

Publication type:

Article

The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer.

Published in:

Oncology, 2023, v. 101, n. 11, p. 695, doi. 10.1159/000532087

By:

Igawa, Satoshi;
Yamamoto, Hiroki;
Yamada, Kaori;
Akazawa, Yuki;
Manaka, Hiroya;
Yagami, Yuri;
Nakahara, Yoshiro;
Sato, Takashi;
Mitsufuji, Hisashi;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 11, p. 730, doi. 10.1159/000531870

By:

Chamseddine, Shadi;
Mohamed, Yehia I.;
Lee, Sunyoung S.;
Yao, James C.;
Hu, Zishuo Ian;
Tran Cao, Hop S.;
Xiao, Lianchun;
Sun, Ryan;
Morris, Jeffrey S.;
Hatia, Rikita I.;
Hassan, Manal;
Duda, Dan G.;
Diab, Maria;
Mohamed, Amr;
Nassar, Ahmed;
Datar, Saumil;
Amin, Hesham M.;
Kaseb, Ahmed Omar

Publication type:

Article

Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.

Published in:

Oncology, 2023, v. 101, n. 11, p. 723, doi. 10.1159/000531722

By:

Bardakci, Murat;
Demirtas Esmer, Derya;
Hafizoglu, Emre;
Yaslikaya, Sendag;
Genc, Tugrul Burak;
Ozcelik, Melike;
Erdat, Efe Cem;
Hendem, Engin;
Buyukbayram, Mehmet Emin;
Alaca Topcu, Zeynep;
Kalkan, Ziya;
Yildirim, Nilgun;
Celebi, Abdussamet;
Ergun, Yakup;
Paydas, Semra;
Tatli, Ali Murat;
Karakas, Hilal;
Koseci, Tolga;
Sendur, Mehmet Ali Nahit

Publication type:

Article

Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint Inhibitors.

Published in:

Oncology, 2023, v. 101, n. 9, p. 537, doi. 10.1159/000529644

By:

Chiang, Cho-Han;
Chen, Yuan-Jen;
See, Xin Ya;
Chang, Yu-Cheng;
Wang, Shih-Syuan;
Peng, Chun-Yu;
Horng, Chuan-Sheng;
Hsia, Yuan Ping;
Chiang, Cho-Hung;
Peng, Cheng-Ming;
Chiang, Cho-Hsien

Publication type:

Article

The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.

Published in:

Oncology, 2023, v. 101, n. 11, p. 685, doi. 10.1159/000530809

By:

Akazawa, Yuki;
Igawa, Satoshi;
Yamada, Kaori;
Yamamoto, Hiroki;
Yagami, Yuri;
Kaizuka, Nobuki;
Manaka, Hiroya;
Kasajima, Masashi;
Nakahara, Yoshiro;
Sato, Takashi;
Mitsufuji, Hisashi;
Yokoba, Masanori;
Kubota, Masaru;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.

Published in:

Oncology, 2023, v. 101, n. 9, p. 575, doi. 10.1159/000530987

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Fujimasa;
Kato, Kanako;
Fukunishi, Yoshiko;
Yanagihara, Emi;
Kato, Masaya;
Saneto, Hironobu;
Izumoto, Hirofumi;
Ueki, Hidetaro;
Yoshino, Takeaki;
Kitahata, Shogo;
Kawamura, Tomoe;
Kuroda, Taira;
Suga, Yoshifumi;
Miyata, Hideki;
Hirooka, Masashi;
Abe, Masanori;
Matsuura, Bunzo;
Ninomiya, Tomoyuki

Publication type:

Article

Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 10, p. 655, doi. 10.1159/000531689

By:

Takada, Hitomi;
Yamashita, Koji;
Osawa, Leona;
Komiyama, Yasuyuki;
Nakakuki, Natsuko;
Muraoka, Masaru;
Suzuki, Yuichiro;
Sato, Mitsuaki;
Kobayashi, Shoji;
Yoshida, Takashi;
Takano, Shinichi;
Maekawa, Shinya;
Enomoto, Nobuyuki

Publication type:

Article

Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm.

Published in:

Oncology, 2023, v. 101, n. 9, p. 553, doi. 10.1159/000527716

By:

Hingorani, Mohan;
Goody, Rebecca;
Bozas, Georgios;
Zahid, Khwaja;
Mitton, David James;
Jain, Prashant;
Wong, Vincent;
Roy, Rajarshi

Publication type:

Article

Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 10, p. 634, doi. 10.1159/000531562

By:

Nagai, Hidenari;
Amanuma, Makoto;
Mukozu, Takanori;
Kobayashi, Kojiro;
Nagumo, Hideki;
Mohri, Kunihide;
Watanabe, Go;
Yoshimine, Naoyuki;
Ogino, Yu;
Daido, Yasuko;
Matsukiyo, Yasushi;
Matsui, Teppei;
Wakui, Noritaka;
Momiyama, Koichi;
Higai, Koji;
Matsuda, Takahisa;
Igarashi, Yoshinori

Publication type:

Article

Intralesional Chemotherapy for Prostate Cancer: In vivo Proof of Principle.

Published in:

Oncology, 2023, v. 101, n. 10, p. 645, doi. 10.1159/000531494

By:

Jotatsu, Yura;
Shigemura, Katsumi;
Arbiser, Jack L;
Moriwaki, Michika;
Hirata, Yuto;
Maeda, Koki;
Yang, Young-min;
Fujisawa, Masato

Publication type:

Article

Recent Developments in Diagnostic and Prognostic Biomarkers for Colorectal Cancer: A Narrative Review.

Published in:

Oncology, 2023, v. 101, n. 10, p. 675, doi. 10.1159/000531474

By:

Giannopoulou, Nefeli;
Constantinou, Constantina

Publication type:

Article

Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database.

Published in:

Oncology, 2023, v. 101, n. 10, p. 664, doi. 10.1159/000531390

By:

Yamaoka, Kenta;
Fujiwara, Masaki;
Uchida, Mayako;
Uesawa, Yoshihiro;
Muroi, Nobuyuki;
Shimizu, Tadashi

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 10, p. 609, doi. 10.1159/000531111

By:

Takada, Hitomi;
Yamashita, Koji;
Osawa, Leona;
Komiyama, Yasuyuki;
Nakakuki, Natsuko;
Muraoka, Masaru;
Suzuki, Yuichiro;
Sato, Mitsuaki;
Takano, Shinichi;
Fukasawa, Mitsuharu;
Yamaguchi, Tatsuya;
Maekawa, Shinya;
Takahashi, Kazuya;
Uchimura, Kohei;
Enomoto, Nobuyuki

Publication type:

Article

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 9, p. 1, doi. 10.1159/000533949
Publication type:: Article

Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based Chemotherapy.

Published in:

Oncology, 2023, v. 101, n. 9, p. 584, doi. 10.1159/000531318

By:

Hayashi, Toshinobu;
Shimokawa, Mototsugu;
Matsuo, Koichi;
Uchiyama, Masanobu;
Kawada, Kei;
Nakano, Takafumi;
Egawa, Takashi

Publication type:

Article

Response Prediction Model of Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Retrospective Study.

Published in:

Oncology, 2023, v. 101, n. 9, p. 565, doi. 10.1159/000531317

By:

Ueno, Masaki;
Kosaka, Hisashi;
Iida, Hiroya;
Ida, Yoshiyuki;
Aoi, Kazunori;
Mori, Haruki;
Miyamoto, Atsushi;
Nishida, Yuko;
Hayami, Shinya;
Kawai, Manabu;
Kaibori, Masaki

Publication type:

Article

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 8, p. 1, doi. 10.1159/000533681
Publication type:: Article

Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with Mechanistic Target of Rapamycin Signaling.

Published in:

Oncology, 2023, v. 101, n. 8, p. 520, doi. 10.1159/000531475

By:

Nakazawa, Nobuhiro;
Sohda, Makoto;
Katayama, Ayaka;
Ide, Munenori;
Shimoda, Yuki;
Tateno, Kohei;
Watanabe, Takayoshi;
Sano, Akihiko;
Sakai, Makoto;
Yokobori, Takehiko;
Ogawa, Hiroomi;
Oyama, Tetsunari;
Shirabe, Ken;
Saeki, Hiroshi

Publication type:

Article

Peripheral Blood-Derived CircVPS35L as a Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer.

Published in:

Oncology, 2023, v. 101, n. 8, p. 527, doi. 10.1159/000531357

By:

Liang, Nan;
Zhang, Xun;
Zhang, Luyi;
Jiang, Meina;
Bai, Huihui;
Ding, Chenhang;
Cai, Yuanting;
Zhou, Chengwei;
Han, Ying;
Gong, Zhaohui

Publication type:

Article

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 7, p. 1, doi. 10.1159/000533557
Publication type:: Article

Predictive Factors Associated with Long-Term Response to Combination Immunotherapy in Patients with Untreated Advanced Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study.

Published in:

Oncology, 2023, v. 101, n. 7, p. 425, doi. 10.1159/000531324

By:

Sonehara, Kei;
Ozawa, Ryota;
Hama, Mineyuki;
Nozawa, Shuhei;
Agatsuma, Toshihiko;
Nishie, Kenichi;
Kato, Akane;
Matsuo, Akemi;
Araki, Taisuke;
Komatsu, Masamichi;
Tateishi, Kazunari;
Hanaoka, Masayuki

Publication type:

Article

Erratum.

Published in:: 2023
Publication type:: Correction Notice

Alterations of UHRF Family Expression and UHRF1/ICBP90 Inhibits Phosphatase and Tensin Homolog Expression in Endometrial Cancer.

Published in:

Oncology, 2023, v. 101, n. 7, p. 457, doi. 10.1159/000531209

By:

Yoshimoto, Masafumi;
Tokuda, Aoi;
Eguchi, Ayami;
Nozawa, Yoshihiro;
Mori, Tsutomu;
Yaginuma, Yuji

Publication type:

Article

Gene Expression and Early Radiation Response of Two Distinct Neuroblastoma Cell Lines.

Published in:

Oncology, 2023, v. 101, n. 7, p. 446, doi. 10.1159/000530902

By:

Ritner, Carissa;
Popović, Jelena;
Abouzeid, Aushra;
Li, Ya;
Paunesku, Tatjana;
Papineni, Rao;
Woloschak, Gayle

Publication type:

Article

Circulating Tumor Cells as Diagnostic Markers of Early Gastric Cancer and Gastric Precancerous Lesions.

Published in:

Oncology, 2023, v. 101, n. 8, p. 512, doi. 10.1159/000531323

By:

Cheng, Rui;
Peng, Yang;
Sun, Xiujing;
Zhang, Shutian;
Li, Peng

Publication type:

Article

Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck.

Published in:

Oncology, 2023, v. 101, n. 8, p. 502, doi. 10.1159/000531026

By:

Fukuda, Naoki;
Oki, Ryosuke;
Suto, Hirotaka;
Wang, Xiaofei;
Urasaki, Tetsuya;
Sato, Yasuyoshi;
Nakano, Kenji;
Yunokawa, Mayu;
Ono, Makiko;
Tomomatsu, Junichi;
Mitani, Hiroki;
Takahashi, Shunji

Publication type:

Article

The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.

Published in:

Oncology, 2023, v. 101, n. 8, p. 491, doi. 10.1159/000530991

By:

Chihiro, Kikukawa;
Kawaoka, Tomokazu;
Uchikawa, Shinsuke;
Kinami, Takahiro;
Yamasaki, Shintaro;
Kosaka, Masanari;
Johira, Yusuke;
Yano, Shigeki;
Amioka, Kei;
Naruto, Kensuke;
Ando, Yuwa;
Yamaoka, Kenji;
Teraoka, Yuji;
Uchida, Takuro;
Fujino, Hatsue;
Nakahara, Takashi;
Ono, Atsushi;
Murakami, Eisuke;
Okamoto, Wataru;
Yamauchi, Masami

Publication type:

Article

Diagnostic Value of OPNI in Hepatocellular Carcinoma.

Published in:

Oncology, 2023, v. 101, n. 8, p. 481, doi. 10.1159/000530319

By:

Zhou, Jing;
Yang, Daofeng

Publication type:

Article

The Utility of SUV<sub>max</sub> as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.

Published in:

Oncology, 2023, v. 101, n. 8, p. 473, doi. 10.1159/000530314

By:

Motono, Nozomu;
Mizoguchi, Takaki;
Ishikawa, Masahito;
Iwai, Shun;
Iijima, Yoshihito;
Uramoto, Hidetaka

Publication type:

Article